BSE filing, NSE: CONCORD. Summary written from the filing by ALFA Finder's alert engine.
Concord Drugs Ltd: key numbers
- Share price
- ₹63.55
- Market cap
- ₹83.73 Cr
- Revenue (annual)
- ₹78.74 Cr
- Net profit (annual)
- ₹1.06 Cr
- P/E (TTM)
- 40.8×Sector 45.9×
- Promoter holding
- 45.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Concord Drugs Ltd
All →Concord Drugs Other Announcement
Concord Drugs Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Concord Drugs Annual General Meeting
Concord Drugs Limited held its 31st Annual General Meeting on September 30, 2026. The meeting covered adoption of financial statements, director appointments, and auditor re-appointment.
Concord Drugs Other Announcement
Concord Drugs Limited is notifying shareholders about the annual report web-link as per Regulation 36(1)(b). Shareholders are urged to update their email addresses.
Concord Drugs Annual Report
Concord Drugs Limited submitted its 31st Annual Report for FY 2025-26 and notice of the 31st Annual General Meeting scheduled for 30th September 2026.
Concord Drugs Annual General Meeting
Concord Drugs approved the notice for its 31st AGM on September 30, 2026. The board also finalized director re-appointments and set book closure dates.
Concord Drugs Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 1000.0% YoY
Concord Drugs Ltd reported revenue from operations of ₹20.9 Cr (+53.7% YoY) and net profit of ₹1.1 Cr (+1000.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +1000.0% YoY
Other other announcement announcements
All →Shanthala FMCG Products Other Announcement
Shanthala FMCG declared Regulation 23 related party transaction disclosures do not apply for the year ended 31 March 2026. The company is SME-listed and below the threshold.
Mitsu Chem Plast Other Announcement
Mitsu Chem Plast reported that its statutory auditor, Gokhale & Sathe, converted into Gokhale & Sathe LLP effective 27 August 2026. The engagement and tenure remain unchanged.
Sonu Infratech Other Announcement
Sonu Infratech reported full utilisation of Rs.551.24 lakh raised from warrant conversion, with no deviation. The Audit Committee reviewed the statement and auditors issued no comments.
DOMS Industries Other Announcement
DOMS Industries filed its quarterly shareholding pattern for the period ended 30 September 2026. It is a periodic statement with no transaction or reclassification.
Alphalogic Techsys Other Announcement
Alphalogic Techsys filed its Reg 32 utilisation statement for the quarter ended September 2026. Rs 1.35 Crore raised via warrant allotment was fully used with no deviation.
- Value
- ₹1.35 Cr
SMR Jewels Other Announcement
SMR Jewels filed its quarterly shareholding pattern for the quarter ended 30 September 2026. Promoters and promoter group hold 65.74% of paid-up capital.